Ultrasonographic and Three-Dimensional Analyses at the Glabella and Radix of the Nose for Botulinum Neurotoxin Injection Procedures into the Procerus Muscle

被引:14
作者
Cho, Younghoon [1 ]
Lee, Hyung-Jin [2 ]
Lee, Kang-Woo [2 ]
Lee, Kyu-Lim [2 ]
Kang, Jae Seung [3 ,4 ]
Kim, Hee-Jin [2 ,5 ]
机构
[1] Bodyfriend, Med R&D Ctr, 163 Yangjaecheon Ro, Seoul 06302, South Korea
[2] Yonsei Univ, Human Identificat Res Inst, Dept Oral Biol, BK21 Plus Project,Div Anat & Dev Biol,Coll Dent, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Anat, 103 Daehak Ro, Seoul 03080, South Korea
[4] Seoul Natl Univ, Coll Med, Tumor Immun Med Res Ctr, 103 Daehak Ro, Seoul 03080, South Korea
[5] Yonsei Univ, Coll Engn, Dept Mat Sci & Engn, 50 Yonsei Ro, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
M; procerus; glabella; sellion; radix of the nose; botulinum neurotoxin injection; facial rejuvenation procedures; ultrasonographic imaging; 3D scanning imaging; glabellar transverse line; TOXIN TYPE-A; DOUBLE-BLIND; EFFICACY; SAFETY;
D O I
10.3390/toxins11100560
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Botulinum neurotoxin (BoNT) injections are widely used for facial rejuvenation procedures, and the procerus muscle is a major target in cases of glabellar transverse lines or rhytids. Although there have been many cadaveric studies of the procerus, its depth and thickness have not been investigated thoroughly. The aim of this study was to measure the depth and thickness of the procerus and identify the location of the intercanthal vein using ultrasonographic (US) imaging and the three-dimensional scanning method, which is needed to know to avoid side effects during BoNT injections. The morphology of the procerus was classified into two types based on the US images obtained at the glabella. The procerus was located deeper below the skin surface at the glabella than the sellion (3.8 +/- 0.7 mm versus 2.7 +/- 0.6 mm). The width of the procerus in US images increased from the sellion (10.9 +/- 0.2 mm) to the glabella (14.5 +/- 4.6 mm), whereas its thickness decreased (from 1.6 +/- 0.6 mm to 1.1 +/- 0.5 mm). The intercanthal vein was located 5.1 +/- 4.0 mm superior to the sellion and 3.0 +/- 0.6 mm below the skin's surface. The present findings provide anatomical knowledge as well as the reference location information for use when injecting BoNT into the procerus.
引用
收藏
页数:9
相关论文
共 25 条
[1]   Severe, intractable headache after injection with botulinum A exotoxin: Report of 5 cases [J].
Alam, M ;
Arndt, KA ;
Dover, JS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (01) :62-65
[2]   Correlation of Botulinum Toxin Dose with Neurophysiological Parameters of Efficacy and Safety in the Glabellar Muscles: A Double-blind, Placebo-controlled, Randomized Study [J].
Alimohammadi, Mohammad ;
Andersson, Mats ;
Punga, Anna Rostedt .
ACTA DERMATO-VENEREOLOGICA, 2014, 94 (01) :32-37
[3]   Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A [J].
Alster, TS ;
Lupton, JR .
DERMATOLOGIC SURGERY, 2003, 29 (05) :516-518
[4]  
Brown T.M., 2019, ANATOMY HEAD NECK PR
[5]   Eyebrow height after botulinum toxin type A to the glabella [J].
Carruthers, Alastair ;
Carruthers, Jean .
DERMATOLOGIC SURGERY, 2007, 33 :S26-S31
[6]   Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type a for patients with glabellar lines [J].
Carruthers, JD ;
Lowe, NJ ;
Menter, MA ;
Gibson, J ;
Eadie, N .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 112 (04) :1089-1098
[7]   A case report of cavernous sinus thrombosis after trauma [J].
Choi, Karen Y. ;
Yang, Christina J. .
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2017, 95 :101-103
[8]   ULTRASONOGRAPHIC ANALYSES OF THE FOREHEAD REGION FOR INJECTABLE TREATMENTS [J].
Choi, You-Jin ;
Lee, Kang-Woo ;
Gil, Young-Chun ;
Hu, Kyung-Seok ;
Kim, Hee-Jin .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2019, 45 (10) :2641-2648
[9]   Botulinum toxin A (Botox® cosmetic): A review of its use in the treatment of glabellar frown lines [J].
Frampton, JE ;
Easthope, SE .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (10) :709-725